Amarin Corp AMRN

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.01 (-0.99%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Amarin Corp (AMRN)
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $0.53

  • Market Cap

    $218.01 Million

  • Price-Earnings Ratio

    -5.30

  • Total Outstanding Shares

    411.34 Million Shares

  • Total Employees

    275

  • Dividend

    No dividend

  • IPO Date

    April 1, 1993

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    American Depository Receipt Common

  • Headquarters

    Spaces south docklands, block c, Dublin 2, L2, D02 VK60

  • Homepage

    https://www.amarincorp.com

Historical Stock Splits

If you bought 10 shares of AMRN before January 18, 2008, you'd have 1 share today.
Execution DateSplit Amount
January 18, 20081-for-10 (Reverse Split)

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities$-94.14 Million
Net Cash Flow From Operating Activities$-18.36 Million
Net Cash Flow From Financing Activities, Continuing$-1.38 Million
Net Cash Flow From Investing Activities, Continuing$-94.14 Million
Net Cash Flow$-113.87 Million
Net Cash Flow From Operating Activities, Continuing$-18.36 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Costs And Expenses$270.76 Million
Income/Loss From Continuing Operations After Tax$-39.35 Million
Basic Average Shares$821.88 Million
Basic Earnings Per Share$-0.10
Gross Profit$136.07 Million
Preferred Stock Dividends And Other Adjustments$0

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-39.35 Million
Comprehensive Income/Loss$-39.35 Million
Other Comprehensive Income/Loss$0
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Fixed Assets$24,000
Current Assets$650.22 Million
Equity Attributable To Parent$531.38 Million
Other Current Liabilities$161.05 Million
Current Liabilities$201.55 Million
Inventory$224 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about AMRN from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    â“’ 2025 Financhle. All Rights Reserved.